Tegmine Therapeutics, Inc.

Company ID 4081617 Status Active

Tegmine Therapeutics, Inc. was incorporated as a Stock Corporation - Out Of State - Stock on November 7, 2017, with its office address at 329 Oyster Point Blvd 3rd Floor, South San Francisco, CA 94080. It is registered with the Delaware Division of Corporations and is authorized to conduct business in California. Jeffrey Robert Bernstein serves as the registered agent. The company is currently active. It has been operating for 7 years, 8 months and 25 days.

Contact

Mail Address

329 Oyster Point Blvd 3rd Floor, South San Francisco, CA 94080

Unreported

Telephone

Website

Go to website

Social Media

Basic Information

Updated: 2024-05-03

Company Name

Tegmine Therapeutics, Inc.

Company ID

4081617

Date of Registration

2017-11-07

Jurisdiction

Delaware

State

California

Type

Stock Corporation - Out Of State - Stock

Office Address

329 Oyster Point Blvd 3rd Floor, South San Francisco, CA 94080

Status

Active

Agent Information

Agent Name: Jeffrey Robert Bernstein

Address: 329 Oyster Point Blvd 3rd Floor

Latest Activity & Filing History

Statement of Information

2023-08-24

Statement of Information

2022-11-29

System Amendment - SI Delinquency for the year of 0

2018-04-26

Initial Filing

2017-11-07

Date	Amendment Type	Changed From	Changed To
2022-11-29	Principal Address 1	4104 24th St Ste Pmb 405	329 Oyster Point Blvd
2022-11-29	Principal Address 2		3rd Floor
2022-11-29	Principal City	San Francisco	South San Francisco
2022-11-29	Principal Postal Code	94114	94080
2022-11-29	Annual Report Due Date	11/30/2022	11/30/2023